Arsena, H. and Munir, S. M. (2026) “Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials”, Bioscientia Medicina : Journal of Biomedicine and Translational Research, 10(7), pp. 2624-2636. doi: 10.37275/bsm.v10i7.1638.